Midi vs Stella: Which Menopause HRT Provider Is Right for You? (2026)

Consumer information only — not medical advice. Editorial standards

Midi vs Stella really comes down to two questions — and most comparison pages fumble the first one. One: do you want testosterone? Two: do you want a clinical-first practice, or a coaching-and-app experience? (Price follows that second answer.) The short version: Pick Midi if testosterone, PPO insurance, or lab-ready clinical care matter most — it prescribes testosterone for women in 24 states, bills most PPO plans, and runs real video visits with labs when needed. Pick Stella if cost is the single priority and testosterone isn't on the table — its self-pay visits are $50 less up front and $60 less per follow-up, and it includes a menopause app with unlimited coaching.

What flips the answer? Usually one detail: testosterone. Both clinics see patients in all 50 states, both prescribe FDA-approved hormone therapy to your own pharmacy, and both take insurance. The real fork is what each one can'tdo. We'll show you exactly where that line falls, what each provider verified-costs, and who should walk away from both.

Midi vs Stella at a glance

The fast answer: Midi is the stronger default if you want testosterone, plan to use PPO insurance, or want lab-ready clinical care; it's the only one of the two that prescribes testosterone for women (in 24 states). Stella is the better pick if you want a lower cash visit price — roughly $110–$230 less a year — and built-in coaching, and you don't need testosterone. Both have clinicians in all 50 states and prescribe FDA-approved hormone therapy sent to your own pharmacy.

Prices and policies verified from each provider's own site on June 4, 2026. Visit prices do not include lab work or prescription costs. Confirm details on the provider's site before booking.

Midi vs Stella: which one should you choose?

Choose Midi if your decision depends on testosterone, PPO insurance, or lab-based clinical care. Choose Stellaif you want a lower self-pay visit price and coaching-plus-app support, and you don't need testosterone. Both see patients in all 50 states, so the biggest real tiebreaker is testosterone: Midi offers it; Stella has no U.S. testosterone option and runs a waitlist instead.

Both are real menopause clinics with menopause-trained clinicians. Neither is a scammy “wellness funnel.” The choice isn't good vs. bad — it's which one removes your specific friction with the fewest surprises.

Find your row:

How much do Midi and Stella cost?

Stella has the lower published self-pay visit prices: $200 for a first visit and $90 for follow-ups, versus Midi's $250 first visit and $150 follow-ups. With in-network insurance, Stella lists an average copay of about $45 per visit, while Midi patients pay their plan's copay or coinsurance. Neither visit price includes lab work or prescription medication.

Insurance terms defined, because they decide your real bill:

• Copay— a flat fee you pay per visit (say, $30).
• Coinsurance— a percentage you pay (say, 20%) after your deductible.
• Deductible— what you pay out of pocket before insurance starts covering.
• In-network— the provider has a contract with your plan, so you pay less.

Side-by-side visit costs

The cost trap: “takes insurance” does not mean free

In-network is not the same as free. You can still owe a deductible, a copay, coinsurance, the full cost of your medication, and any lab fees. Both Midi and Stella say plainly that coverage varies by plan. Read your benefits before you book — because the single most common complaint about Midi is the surprise bill: “I was told it was covered, then got billed.”

What a first year actually costs (self-pay)

Using each provider's listed prices, before medication:

Visit-only math; does not include medication, lab work, or insurance adjustments. If sticker price is your only concern and you're paying cash, Stella wins the year. If you have PPO insurance, the gap mostly disappears and other things — testosterone, lab-based care — matter more.

Do Midi and Stella both prescribe real HRT?

Yes. Both can prescribe real menopause hormone therapy, sent to your own pharmacy, when it's clinically appropriate. Midi prescribes FDA-approved hormone therapy — including estradiol patches, pills, vaginal rings, gels, and creams, plus progesterone. Stella prescribes FDA-approved hormone therapy like estrogen and progesterone, along with non-hormonal options. Neither is a compounding-first operation for core menopause care; compounded products only appear for testosterone (Midi only).

Quick definitions, because this is where marketing gets slippery:

• HRT / hormone therapy (HT)— using hormones like estrogen (often as estradiol) and progesterone to ease menopause symptoms. (The FDA now prefers “hormone therapy” over “HRT,” but most people still search “HRT.”)
• Vasomotor symptoms— the medical term for hot flashes and night sweats.
• Genitourinary syndrome of menopause (GSM)— vaginal dryness, irritation, and related urinary symptoms, often treated with low-dose vaginal estrogen.

What each one prescribes — and the one category that's different

FDA-approved vs. compounded: the distinction that protects you

One safety note if you still have a uterus

If you have a uterus and take systemic estrogen, your clinician should also prescribe a progestogen (progesterone or progestin). Estrogen alone can thicken the uterine lining and raise the risk of endometrial cancer; adding a progestogen lowers that risk. Ask either clinic to walk you through the progesterone plan. A good provider welcomes the question.

Midi vs Stella for testosterone: the real tiebreaker

If testosterone is part of your decision, Midi is the clear pick— Stella doesn't offer it in the U.S. yet. Midi prescribes a compounded testosterone cream made for women in 24 states, using a process of evaluation, lab testing, and usually two visits before any prescription. There is no FDA-approved testosterone product for women in the U.S., so it's prescribed off-label, and testosterone is a Schedule III controlled substance that legally requires a prescription and monitoring. Stella routes interested patients to a waitlist.

Key terms explained

Off-labelmeans a clinician prescribes a medication for a use the FDA hasn't formally approved — legal and common, but the product wasn't reviewed for that specific use. Schedule III controlled substancemeans the government regulates it for misuse potential; you can only get it with a prescription, often in limited quantities, so you'll need repeat visits to refill it. Testosterone for women is not a casual add-on or an instant prescription.

Midi's testosterone program — the verified details

• ✓

  24 states available

  AZ, CA, CO, DC, DE, FL, IA, IL, IN, KS, MA, MD, ME, NJ, NM, NV, NY, OH, OR, PA, TX, UT, VA, and WA. Midi launched in 12 states in late 2025 and has since doubled to 24, with more planned as state rules allow.

• ✓

  Topical cream

  testosterone USP, micronized, made for women — chosen over implanted pellets so the dose can be adjusted.

• ✓

  Two-visit protocol

  most patients have a first visit to review their full health history and labs, then a second visit to confirm whether testosterone is the right fit. Your clinician monitors bloodwork along the way.

• ✓

  Compounded, not FDA-approved

  because no FDA-approved testosterone product exists for women in the U.S.

Stella's testosterone status

Not offered in the U.S. Stella tells interested patients to email support to join a waitlist. Stella's parent company has a U.K. footprint where testosterone prescribing for women is more established, but that doesn't help you in the States today.

Heads-up: this involves an evaluation, labs, and usually two visits. It's not a same-day prescription.

Do Midi or Stella require lab work?

Usually not, for either one. Both follow the mainstream menopause guideline that diagnosis is based on your age, symptoms, and history — not routine hormone testing. Stella says lab work isn't usually needed and will explain it if a clinician recommends it. Midi may order labs or imaging when needed, and its visit prices don't include them. The clear exception is testosterone: Midi requires lab testing and monitoring before and during a testosterone prescription.

Some clinics make you pay hundreds of dollars in bloodwork before they'll treat you. Neither of these two does that for standard menopause care. If “do I have to get labs first?” was a sticking point, you can relax for general menopause care with either provider. Budget for labs mainly if you're pursuing testosterone (Midi, 24 states) or you have a specific issue a clinician wants to investigate.

Insurance, Medicare, Medicaid, HSA, and FSA

Both Midi and Stella are insurance-first, but the details decide everything. Midi is in-network with most PPO plans but cannot treat Medicaid or Medi-Cal patients — even as self-pay — and is not covered by Medicare (Medicare beneficiaries can self-pay but can't submit claims). Stella is in-network with hundreds of plans including Aetna, Anthem, Blue Cross Blue Shield, and UnitedHealthcare, with an average copay around $45, plus HSA/FSA and superbills; its Medicare and Medicaid policies aren't published, so confirm directly.

The hard limits, stated plainly

Your pre-booking insurance checklist

1. 1Is the clinician in-network for your exact plan? (Stella bills insurance in most states; elsewhere it’s self-pay with a superbill.)
2. 2Is your plan PPO, HMO, EPO, Medicare, Medicaid, or employer-sponsored?
3. 3Have you met your deductible this year?
4. 4Will visits have a copay or coinsurance?
5. 5Are prescriptions covered under your pharmacy benefit?
6. 6Does the provider take HSA/FSA? (Both do.)
7. 7Will you need a superbill for out-of-network reimbursement? (Stella offers one — up to 80% if your plan has OON benefits.)
8. 8Are you seeking testosterone? (Midi, 24 states only.)

What happens after you start with Midi or Stella?

Midi runs a clearer clinical visit structure: a health questionnaire, a 30-minute first visit, 15-minute follow-ups, a care plan, and labs or imaging when needed. Stella runs virtual visits with menopause specialists — often same-week, with same-day prescriptions when appropriate — plus a menopause app and unlimited coaching included. Midi leans clinical and lab-ready; Stella leans coaching-and-support.

If you want a structured clinical path with labs on tap, Midi's flow is more transparent. If you want day-to-day support — habit plans, coaching, a community — Stella's included app is the standout.

Who should NOT use Midi or Stella?

Neither Midi nor Stella replaces emergency care, urgent evaluation, or in-person exams like Pap smears and mammograms. Midi specifically can't treat Medicaid/Medi-Cal patients and isn't covered by Medicare. Stella isn't the right first choice for U.S. patients who want testosterone, since it doesn't offer it yet. If your situation is medically complex, get a clinician's eyes on it before booking either.

Walk away from both — for now — if:

• !You have emergency or urgent symptoms. Call your doctor or 911.
• !You have Medicaid or Medi-Cal and were eyeing Midi. It’s a no, even self-pay.
• !You have Medicare and need to submit claims. Midi can’t do that.
• !You want testosterone and you’re looking at Stella in the U.S. Not available.
• !You need a Pap smear, breast exam, mammogram, or pelvic exam. Keep your local care.

Be cautious — talk to a clinician first — if you have a history of hormone-sensitive cancer, blood clots or stroke, unexplained bleeding, active liver disease, or you're not sure your symptoms are even menopause-related.

What Midi does better — and the one place it loses

Midi is stronger when you want testosterone, PPO insurance billing, or lab-based clinical care. It publishes detailed pricing, clear insurance limits, a defined visit structure, FDA-approved hormone forms, and testosterone availability across 24 states, backed by a large U.S. patient base. Its tradeoff is cost: Midi has the higher self-pay visit price in this matchup.

Where Midi pulls ahead:

• ✓

  Testosterone in 24 states with labs and monitoring — the capability Stella can’t match in the U.S.

• ✓

  In-network with most PPO plans — if you have a PPO, start here.

• ✓

  Clear visit structure 30-minute first visit, 15-minute follow-ups, published pricing.

• ✓

  FDA-approved hormone forms patch, pill, ring, gel, cream, plus progesterone.

• ✓

  Large U.S. track record 200,000+ patients, so there’s real history behind it.

For the full picture, read our complete Midi Health review.

The one honest knock:

Midi is notthe cheapest cash-pay option here. If the lowest sticker price is your single priority and you don't need testosterone, Stella's $200/$90 self-pay visits beat Midi's $250/$150. But here's why that gap is small for most people comparing these two: Midi's higher cash price comes with a broader clinical model — real video visits, lab ordering when needed, insurance billing, and a testosterone program in 24 states. If you have PPO insurance, the price gap mostly vanishes. If you want testosterone, Stella can't match that. The cash-only price-shopper should go to Stella; almost everyone else is choosing on capability, not $110 a year.

What Stella does better than Midi

Stella is stronger for a lower self-pay visit price, a coaching-and-app experience, and straightforward FDA-approved estrogen/progesterone or non-hormonal care. Its main limit in this matchup: no U.S. testosterone, plus a smaller, newer U.S. track record than Midi.

Where Stella pulls ahead:

• ✓

  Lower self-pay visits $200 first, $90 follow-up — $50/$60 less per visit than Midi.

• ✓

  Menopause app + unlimited coaching included the clearest differentiator, with habit tools, symptom tracking, and a resource library.

• ✓

  In-network with hundreds of plans ~$45 average copay.

• ✓

  Superbills up to 80% out-of-network reimbursement if your plan has OON benefits.

• ✓

  Board-certified menopause specialists several NCMP-certified (North American Menopause Society), and a 65-point risk screen.

For the full picture, read our complete Stella Menopause review.

The honest knocks:Stella has no U.S. testosterone option (waitlist only), and its U.S. arm is newer and smaller than Midi's. In a state where Stella isn't in-network, you self-pay and use the superbill. None of that makes it a bad choice — it makes it a specificchoice: best when you want affordable, coaching-forward menopause care and testosterone isn't on the table.

The 2026 FDA change — and why it matters here

On February 12, 2026, the FDA approved the first six updated hormone-therapy labels. The update removes the boxed-warning language about heart disease, stroke, blood clots, breast cancer, and probable dementia, but keeps the boxed warning about endometrial (uterine) cancer for systemic estrogen-alone products. New labeling emphasizes timing — starting before age 60 or within 10 years of menopause.

For 22 years, menopause hormone products carried the FDA's strongest warning — a “boxed warning” about strokes, blood clots, heart problems, and dementia, rooted in an early-2000s study of older women using an older formulation. Many doctors said that warning scared off women who could have benefited. In late 2025 the FDA moved to remove it. By February 12, 2026, the first batch of products had updated labels — including Prometrium (progesterone), Divigel (estradiol gel), and Estring (vaginal estrogen).

Two things to hold onto: The endometrial-cancer warning stays for systemic estrogen-alone products — if you have a uterus, the progesterone conversation above still matters. And removing a warning is not a green light for everyone— hormone therapy is the most effective treatment for hot flashes and GSM, but the risk-benefit picture depends on your age, timing, dose, route, and history. That's exactly the individualized conversation a menopause-trained clinician is there to have.

What real users say about Midi and Stella

Patient reviews describe relief and a sense of being taken seriously, but they're individual experiences, not proof of typical results. As of mid-2026, Midi holds about a 4.0/5 score across roughly 1,300 Trustpilot reviews and replies to the large majority of critical ones. Stella publishes patient testimonials and has a newer, smaller U.S. review base. Use reviews for tone and expectations — not as medical evidence.

The deepest fear we hear from readers isn't about price. It's: “Will I pay for another appointment and still get dismissed?”That's the bar both providers are trying to clear.

These quotes show real experiences and the kind of relief people hope for. They don't imply typical results, and they aren't medical evidence. Your outcome depends on your body, your clinician, and your treatment plan. Midi's most common complaint theme is billing confusion — patients told a visit was covered, then getting a bill. That's a reason to verify your coverage before you book, not a reason to avoid Midi.

How we compared Midi vs Stella

We compared Midi and Stella on the decisions a real person makes before booking: cost, insurance, testosterone, hormone therapy, labs, follow-up, coaching, and disqualifiers. Commercial facts (pricing, coverage, policies) were verified from each provider's own site on June 4, 2026. Medical and regulatory facts were checked against the FDA, the DEA, and a global consensus of menopause and sexual-health societies. Anything we couldn't confirm is labeled as such, not filled in with a guess.

We sort every claim into three buckets so you know how much to trust it:

• Commercial facts— pricing, insurance networks, state availability, visit length, provider policies. These come straight from the providers and can change.
• Medical and regulatory facts— FDA status, compounded-vs-approved distinctions, testosterone’s Schedule III status and evidence-based use. These come from the FDA, the DEA, and medical-society guidance.
• Editorial judgments— our "best for" calls. These are conclusions built on the verified facts above. They are not medical advice.

Midi vs Stella FAQ

Still not sure which one fits you?

You came here to make one decision: Midi or Stella. If your situation is clear — you want testosterone (Midi) or the lowest cash visit price plus coaching (Stella) — go check that provider's eligibility and pricing now, while it's fresh.

If you're on the fence, or you're in a spot where neither is a clean fit — Medicaid/Medi-Cal, unclear Medicare coverage, or testosterone outside Midi's 24 states — don't force it.

The HRT Index is an independent comparison resource for HRT telehealth providers. We are not a medical provider, and this page is not medical advice. Talk to a licensed clinician about your symptoms, history, and risks before starting or changing any treatment.